Mangalam Drugs and Organics Share Price
23 Oct, 2026 3:52 PM (IST)
Mangalam Drugs and Organics Performance
- Today's Low
- ₹28
- Today's High
- ₹30
- 52 Week Low
- ₹23
- 52 Week High
- ₹71
- Open Price₹30
- Previous Close₹30
- Volume22,247
- 50 DMA₹30.70
- 100 DMA₹30.70
- 200 DMA₹35.40
Mangalam Drugs and Organics Chart
Investment Returns
- Over 1 Month -11.36%
- Over 3 Month + 5.45%
- Over 6 Month + 1.24%
- Over 1 Year -59.16%
Smart Investing Starts Here Start SIP with Mangalam Drugs and Organics for Steady Growth!
Mangalam Drugs and Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -1.2
- PEG Ratio
- 0
- Market Cap Cr
- 45
- P/B Ratio
- 0.5
- Average True Range
- 2
- EPS
- -24.2
- Dividend Yield
- 0
- MACD Signal
- -0.3
- RSI
- 39.02
- MFI
- 31.61
Latest Stock News Updates
Subsequent Intimation for Bank Default under Para A of Schedule III of Regulation 30 of SEBI (LODR), 2015.
- BSE India
- 1 week 1 day ago
Intimation of Certificate received from RTA i.e. MUFG Intime India Private Limited under Regulation 74(5) of DP, 2018 for the quarter ended September 30, 2026
- BSE India
- 2 weeks 3 days ago
Intimation under Regulation 30 of SEBI (LODR),2015 for Newspaper publication regarding issuance of postal ballot notice for appointment of Mr. Prabhakar Raghunath Zavar as Independent Director.
- BSE India
- 3 weeks ago
Mangalam Drugs and Organics Financials
Mangalam Drugs and Organics Technicals
EMA & SMA
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹30.90
- 50 Day
- ₹30.70
- 100 Day
- ₹30.70
- 200 Day
- ₹35.40
Resistance and Support
- R3 32.50
- R2 31.40
- R1 30.00
- S1 27.60
- S2 26.60
- S3 25.20
Mangalam Drugs and Organics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-12 | Quarterly Results | |
| 2026-05-14 | Audited Results | |
| 2026-03-26 | Others | Inter-alia, to consider 1. Taking note of Resignation of Ms. Anuradha Pandey as Company Secretary & Compliance Officer. 2. Appointment of Ms. Shweta Patel as Company Secretary & Compliance Officer. |
| 2026-02-06 | Others | |
| 2026-01-15 | Quarterly Results |
About Mangalam Drugs and Organics
Mangalam Drugs and Organics in the manufacture and sale of Active Pharmaceutical Ingredients (API) for various therapeutic segments viz. Anti-Malaria, Anti-Retrovirat, Anti-Hypertensive etc. It is the only API company globally to qualify under the Bill Clinton Foundation for supply of Anti-Malarial drugs and is amongst the 8 players globally (6 Formulators and 2 API players) with WHO prequalification for Anti-Malaria APIs- Artemether and Lumefantrine. View More- NSE Symbol
- MANGALAM
- BSE Symbol
- 532637
- ISIN
- INE584F01014
Similar Stocks to Mangalam Drugs and Organics
Popular Stocks
Mangalam Drugs and Organics FAQs
Mangalam Drugs and Organics share price is ₹28 As on 25 October, 2026 | 04:22
The Market Cap of Mangalam Drugs and Organics is ₹45.3 Cr As on 25 October, 2026 | 04:22
The P/E ratio of Mangalam Drugs and Organics is -1.2 As on 25 October, 2026 | 04:22
The PB ratio of Mangalam Drugs and Organics is 0.5 As on 25 October, 2026 | 04:22
The 52 week High & Low of Mangalam Drugs and Organics is ₹70.9/₹22.8 respectively As on 25 October, 2026 | 04:22
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.